Ionis Announces Submission of Marketing Authorization Application for Inotersen to the EMA Post author:Sam Post published:November 2, 2017 Post category:BioPharma The MAA will be reviewed under the EMA’s Accelerated Assessment program. Source: BioSpace You Might Also Like <b>Bluechiip Ltd</b> Half Yearly Report And Accounts February 22, 2017 Nephron Pharma to Create 125 New Jobs in Expansion December 6, 2017 Medtech Innovative Health Solutions to Create New Jobs in Expansion November 20, 2017
